A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
EvolveImmune United, Inc
OncoC4, Inc.
Sotio Biotech Inc.
Novartis
Incyte Corporation
Jonsson Comprehensive Cancer Center
Shattuck Labs, Inc.
The Affiliated Hospital of Qingdao University
Gene Surgery LLC
Shanghai Bovax Biotechnology Co., Ltd.
HRYZ Biotech Co.
HRYZ Biotech Co.
Xencor, Inc.
Xencor, Inc.
Genocea Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
Oryx GmbH & Co. KG
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mannkind Corporation
Case Comprehensive Cancer Center